Universal Biosensors (ASX:UBI) develops and manufactures diagnostic test systems for point-of-care (POC) professional and home use – a market worth about $US15 billion and growing at ~10% annually.
UBI’s core technology is a disposable, multi-layer test strip which uses a proprietary electrochemical sensor to rapidly, accurately and cost-effectively measure biomarkers in...